Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and Lymphangiomatosis 2022

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of December 2020 was searched in PubMed and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution Service (Minds) technique. A total of 38 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, pathological diagnosis deciding the diagnosis, and causal genes of vascular anomalies. Thus, the Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

Authors

Institutions

Publication Details

Journal
Pediatrics International
Published
2026-01-01
DOI
https://doi.org/10.1111/ped.70333
Primary Topic
Vascular Malformations and Hemangiomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and Lymphangiomatosis 2022

Kumiko Chuman, Masakazu Kurita, Shohei Takami, Hayato Maruguchi et al.
Pediatrics International
Vascular Malformations and Hemangiomas
article

Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and Lymphangiomatosis 2022

Kumiko Chuman, Masakazu Kurita, Shohei Takami, Hayato Maruguchi, Shinji Wada, Akihiro Fujino, Fumio Nagai, Kyoichi Deie, Takeshi Hirabayashi, Masashi Tamura, Tamotsu Kobayashi, Norifumi Matsuda, Akira Higashiyama, Kiyokazu Kim, Noriko Aramaki‐Hattori, Kohji Yamamoto, Shuichi Tanoue, Sadanori Akita, Mizuki Uchiyama, Hiroki Yoshihara, Akiko Asai, Tomo Kakihara, Takanobu Maekawa, Kiichiro Yaguchi, Akifumi Nozawa, Keigo Osuga, Michio Ozeki, Yuki Iwashina, Yuta Nakajima, Tamihiro Kawakami, Shunsuke Yuzuriha, Tadashi Nomura, Sachiko Asayama, Shinsuke Takagi, Daisuke Maeda, Shiho Yasue, Hidehito Usui, Katsuyoshi Koh, Yasuyuki Yamahana, Eiichi Morii, Y. Aoki, Mayu Uka, Shien Seike, Junko Ochi, Kosuke Ishikawa, Asami Tozawa, Shinji Kagami, Naoya Oshima, Shunsuke Nosaka, Ami Kawaguchi, Nobuyuki Takakura, Naoaki Rikihisa, Yusuke Shikano, Rika Yoshimatsu, Naoki Murakami, Yohei Iwata, Masatoshi Jinnin, Daichi Hayashi, Akira Kitagawa, Masataka Takahashi, Takafumi Ohshiro, Akira Morimoto, Yasunari Niimi, Yoshiaki Kinoshita, Yuhki Arai, Mamoru Honda, Akiko Kishi, Shuichi Shimada, Aya Tanaka, Rintaro Ono, Keiji Suzuki, Ayato Hayashi, Kazuki Hashimoto, Masafumi Kamata, Reiko Takeda, Hiroki Nakaoka, Taro Kono, Takao Tachibana, Munezumi Fujita, K Ohara, Kaishu Tanaka, Satoshi Hirakawa, Saori Endo, Michiko Nagahama, Mototoshi Kato, Takaya Fukumoto, Kenji Tsuboi, Miho Noguchi, Toshihiro Otsuka, Satoru Sasaki, Yuta Moriwaki, Taizo Furukawa, Yumiko Hori, Kentaro Matsuoka, Yoshihiro Kuwano, Ryo Nakatani, Naoki Hashizume, Hidefumi Mimura, Shiro Onozawa, Takeshi Saito, Hiroshi Furukawa, Hiroshi Kitagawa, Masashi Hayakawa, Mine Ozaki, Motoi Kato, Takahide Kaneko, Masanori Inoue, Daisuke Hasegawa, Yasuhiro Nakamura, Hiroki Kanamori, Hideki Mori, Hideki Endo, Keiko Ogawa, Ryohei Ishiura, Taiki Nozaki, Kanako Danno, Satoru Tamura
article en

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of December 2020 was searched in PubMed and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution Service (Minds) technique. A total of 38 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, pathological diagnosis deciding the diagnosis, and causal genes of vascular anomalies. Thus, the Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

Pediatrics InternationalVol. 68(1)
Kurume University (JP), Osaka Gakuin University (JP), Toho University (JP), Fukushima Medical University (JP), Tokai University (JP), Hamamatsu University (JP), Shinshu University (JP), Fujita Health University (JP), Jichi Medical University (JP), St. Marianna University School of Medicine (JP), Aichi Medical University (JP), Mie University (JP), Wakayama Medical University (JP), Kyorin University (JP), Tohoku University (JP), East Japan Railway (Japan) (JP), Keio University (JP), Hokkaido University (JP), CHI Health (US), Hamamatsu University School of Medicine (JP), Takamatsu University (JP), Kyoto Prefectural University of Medicine (JP), National Defense Medical College Hospital (JP), Kobe Medical Center (JP), St. Luke's International Hospital (JP), Toyonaka Municipal Hospital (JP), Niigata University of Rehabilitation (JP), Matsuyama Shimin Hospital (JP), Kochi Medical School Hospital (JP), Kobe University Hospital (JP), Osaka National Hospital (JP), Yamamoto Hospital (JP), Seiwa Hospital (JP), Hoshigaoka Medical Center (JP), Saitama Children's Medical Center (JP), Ehime Medical Center (JP), Futaba clinic (JP), Okayama University Hospital (JP), Japanese Red Cross Medical Center (JP), Tonan Hospital (JP), Suita Tokushukai Hospital (JP), Gifu University Hospital (JP), University of Tokyo Hospital (JP), Ehime University Hospital (JP), Osaka Rosai Hospital (JP), Kanagawa Children's Medical Center (JP), Mie University Hospital (JP), Nagoya Ekisaikai Hospital (JP), Okayama Psychiatric Medical Center (JP), Kagoshima University Hospital (JP), Amita Health (US), Kumamoto University Hospital (JP), Kanto Central Hospital (JP), Hiroshima University Hospital (JP), Tamashima Hospital (JP), Ono Clinic (JP), National Center For Child Health and Development (JP), Saitama International Medical Center (JP), Saiseikai Matsuyama Hospital (JP), Chiba Hospital (JP), Tohoku Medical Megabank Organization (JP), Tokyo Women's Medical University (JP), Juntendo University Urayasu Hospital (JP), Minamiaoyama Eye Clinic (JP), Otsuka Pharmaceutical (Spain) (ES), Nagano Children's Hospital (JP), Tokyo Metropolitan Children's Medical Center (JP), Japanese Red Cross Society Kyoto Daini Hospital (JP), Okayama Medical Center (JP), Nippon Medical School Hospital (JP), SHOWA Medical University Fujigaoka Hospital (JP), Hokuto Hospital (JP), Kinan Hospital (JP), Hirosaki University Hospital (JP), Municipal Hirakata City Hospital (JP), Toranomon Hospital (JP), Gifu University (JP), National Defense Medical College (JP), Kobe University (JP), Niigata University (JP), The University of Tokyo (JP), Kōchi University (JP), Tohoku Medical and Pharmaceutical University (JP), Saitama Medical University (JP), Teikyo University (JP), Yokohama City University (JP), Osaka University of Pharmaceutical Sciences (JP), The University of Osaka (JP)
Good health and well-being
Openalex Percentile: Top 9%
Vascular Malformations and Hemangiomas
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.